Grape King Bio Ltd

TWSE:1707.TW

151 (TWD) • At close November 14, 2024
Bedrijfsnaam Grape King Bio Ltd
Symbool 1707.TW
Munteenheid TWD
Prijs 151
Beurswaarde 22,368,687,000
Dividendpercentage 4.35%
52-weken bereik 132 - 163.5
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Sheng-Lin Tseng
Website https://www.grapeking.com.tw

An error occurred while fetching data.

Over Grape King Bio Ltd

Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea,

Vergelijkbare Aandelen

Tanvex BioPharma, Inc. logo

Tanvex BioPharma, Inc.

6541.TW

63.3 TWD

ScinoPharm Taiwan, Ltd. logo

ScinoPharm Taiwan, Ltd.

1789.TW

23 TWD

Adimmune Corporation logo

Adimmune Corporation

4142.TW

22 TWD

Pegavision Corporation logo

Pegavision Corporation

6491.TW

369 TWD

YungShin Global Holding Corporation logo

YungShin Global Holding Corporation

3705.TW

53.5 TWD

Excelsior Medical Co., Ltd. logo

Excelsior Medical Co., Ltd.

4104.TW

86.3 TWD

Panion & Bf Biotech Inc. logo

Panion & Bf Biotech Inc.

1760.TW

90.6 TWD

SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc.

4119.TW

94.9 TWD

Standard Chem & Pharm CO., LTD. logo

Standard Chem & Pharm CO., LTD.

1720.TW

63.3 TWD

Lotus Pharmaceutical Co., Ltd. logo

Lotus Pharmaceutical Co., Ltd.

1795.TW

282 TWD

Financiële Gegevens

Cijfers zijn in miljoenen (TWD)

Cijfers zijn in miljoenen (TWD)